Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label … TSK Mok, YL Wu, I Kudaba, DM Kowalski, BC Cho, HZ Turna, G Castro, ... The Lancet 393 (10183), 1819-1830, 2019 | 2837 | 2019 |
KRAS, NRAS, BRAF, HER2 and microsatellite instability in metastatic colorectal cancer–practical implications for the clinician VA Afrăsânie, MV Marinca, T Alexa-Stratulat, B Gafton, M Păduraru, ... Radiology and oncology 53 (3), 265-274, 2019 | 136 | 2019 |
A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma T Ciuleanu, I Bazin, D Lungulescu, L Miron, I Bondarenko, A Deptala, ... Annals of Oncology 27 (4), 680-687, 2016 | 50 | 2016 |
Diagnostic difficulties in a pediatric insulinoma: a case report I Miron, S Diaconescu, G Aprodu, I Ioniuc, MR Diaconescu, L Miron Medicine 95 (11), e3045, 2016 | 30 | 2016 |
Second-line chemotherapy with gemcitabine and oxaliplatin in combination with loco-regional hyperthermia (EHY-2000) in patients with refractory metastatic pancreatic cancer … C Volovat, SR Volovat, V Scripcaru, L Miron Rom Rep Phys 66 (1), 166-174, 2014 | 28 | 2014 |
Research on aromatase gene (CYP19A1) polymorphisms as a predictor of endocrine therapy effectiveness in breast cancer L Miron, L Negura, D Peptanariu, M Marinca The Medical-Surgical Journal 116 (4), 997-1004, 2012 | 20 | 2012 |
Hepatocellular carcinoma: insights in the biological treatment beyond sorafenib B Gafton, V Porumb, S Ungurianu, MV Marinca, C Cocea, A Croitoru, ... J BUON 19 (4), 858-866, 2014 | 19 | 2014 |
The results of combination of ifosfamid and locoregional hyperthermia (EHY 2000) in patients with advanced abdominal soft-tissue sarcoma after relapse of first line chemotherapy SR Volovat, C Volovat, V Scripcaru, L Miron, C Lupascu Romanian Reports in Physics 66 (1), 175-181, 2014 | 18 | 2014 |
Childhood rhabdomyosarcoma. Anatomo-clinical and therapeutic study on 25 cases. Surgical implications S Diaconescu, M Burlea, I Miron, SG Aprodu, D Mihăilă, C Olaru, L Miron Rom J Morphol Embryol 54 (3), 531-37, 2013 | 16 | 2013 |
Laryngotracheal non-Hodgkin's lymphoma. MD Cobzeanu, V Costinescu, CD Rusu, S Mihailovici, M Grigoras, ... Chirurgia (Bucharest, Romania: 1990) 105 (1), 131-136, 2010 | 16 | 2010 |
Incidence of chemotherapy discontinuation and characteristics of elderly patients with non-small cell lung cancer treated with platinum-based doublets T Alexa, A Lavinia, A Luca, L Miron, ID Alexa Contemporary Oncology/Współczesna Onkologia 18 (5), 340-343, 2014 | 14 | 2014 |
Gastroesophageal reflux in children with asthma VV Lupu, I Miron, E Tarca, LM Trandafir, DT Anton-Paduraru, SM Moisa, ... Children 9 (3), 336, 2022 | 12 | 2022 |
Age-related prognostic factors and treatment results for advanced non-small cell lung cancer (NSCLC) D Clement, L Miron, M Marinca Revista Medico-Chirurgicala a Societatii de Medici si Naturalisti din Iasi …, 2007 | 12 | 2007 |
Triple-negative breast cancer--towards a new entity L Miron, A Marinca, M Marinca, I Miron Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi …, 2008 | 10 | 2008 |
A case report of pediatric calciphylaxis–a rare and potentially fatal under diagnosed condition M Stârcea, C Gavrilovici, A Elsayed, M Munteanu, VV Lupu, E Cojocaru, ... Medicine 97 (27), e11300, 2018 | 9 | 2018 |
The relationship between chronic lung diseases and lung cancer-a narrative review O Miron, VA Afrasanie, MI Paduraru, LM Trandafir, L Miron J BUON 25, 1687-92, 2020 | 8 | 2020 |
The Coexistence of RAS and BRAF Mutations in Metastatic Colorectal Cancer: A Case Report and Systematic Literature Review. VA Afrăsânie, B Gafton, MV Marinca, T Alexa-Stratulat, L Miron, C Rusu, ... Journal of Gastrointestinal & Liver Diseases 29 (2), 2020 | 8 | 2020 |
A very rare presentation of lung cancer: Metastases to the distal phalanx of index–case report VA Afrasânie, AM Adavidoaiei, IH Zamisnicu, IG Funingana, MV Marinca, ... Medicine 98 (49), e17892, 2019 | 8 | 2019 |
BRCA1 5382insC founder mutation has not a significative recurrent presence in Northeastern Romanian cancer patients L Negură, CP Duşa, MI Balmuş, D Azoicăi, AM Negură, MV Marinca, ... Rom J Morphol Embryol 56 (2), 379-385, 2015 | 8 | 2015 |
Pleading for the quality of health care: ethics-from the bedside to health institutions C Gavrilovici, S Gavrilescu, L Miron Revista Romana de Bioetica 11 (4), 2013 | 8 | 2013 |